R WE ready for reimbursement? A round up of developments in real-world evidence relating to HTA: part 5-Reference-Cited by-同舟云学术

R WE ready for reimbursement? A round up of developments in real-world evidence relating to HTA: part 5

Published:2022-03 Issue:4 Volume:11 Page:213-215
ISSN:2042-6305
Container-title:Journal of Comparative Effectiveness Research
language:en
Short-container-title:J. Comp. Eff. Res.

Author:

Simpson Alex¹,Ramagopalan Sreeram V¹

Affiliation:

1. Global Access, F Hoffmann-La Roche, Basel, Switzerland

Abstract

In the latest update we focus on recent publications which have provided insights into the importance of focusing on the development and consideration of a body of real-world evidence, and an approach to evaluating the complex area of treatment sequencing.

Publisher

Becaris Publishing Limited

Subject

Health Policy

Link

https://becarispublishing.com/doi/pdf/10.2217/cer-2021-0302

Reference11 articles.

1. The environment and disease: association or causation?;Hill AB;Proc. R. Soc. Med.,1965

2. The Friends of Cancer Research Real-World Data Collaboration Pilot 2.0: methodological recommendations from oncology case studies;Rivera DR;Clin. Pharmacol. Ther.,2022

3. Real-world overall survival using oncology electronic health record data: Friends of Cancer Research Pilot;Lasiter L;Clin. Pharmacol. Ther.,2021

4. Common problems, common data model solutions: evidence generation for health technology assessment;Kent S;Pharmacoeconomics,2021

5. Desirability and acceptability of a treatment-sequencing model in relapsing-remitting multiple sclerosis: a health technology assessment perspective;Piena MA;Int. J. Technol. Assess. Health Care,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges and Opportunities in Interdisciplinary Research and Real-World Data for Treatment Sequences in Health Technology Assessments;PharmacoEconomics;2024-04-01